KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Castle Biosciences (CSTL) Times Interest Earned (2018 - 2025)

Historic Times Interest Earned for Castle Biosciences (CSTL) over the last 8 years, with Q3 2025 value amounting to -$283.5.

  • Castle Biosciences' Times Interest Earned fell 122194.33% to -$283.5 in Q3 2025 from the same period last year, while for Sep 2025 it was -$226.84, marking a year-over-year decrease of 1054257.63%. This contributed to the annual value of $15.03 for FY2024, which is 10024.31% up from last year.
  • Castle Biosciences' Times Interest Earned amounted to -$283.5 in Q3 2025, which was down 122194.33% from -$202.43 recorded in Q2 2025.
  • Castle Biosciences' Times Interest Earned's 5-year high stood at $44.02 during Q4 2024, with a 5-year trough of -$15171.0 in Q4 2021.
  • Moreover, its 5-year median value for Times Interest Earned was -$2235.9 (2023), whereas its average is -$3665.4.
  • Its Times Interest Earned has fluctuated over the past 5 years, first tumbled by 19754330.47% in 2021, then surged by 10155.61% in 2024.
  • Over the past 5 years, Castle Biosciences' Times Interest Earned (Quarter) stood at -$15171.0 in 2021, then soared by 62.38% to -$5708.0 in 2022, then skyrocketed by 50.44% to -$2829.0 in 2023, then surged by 101.56% to $44.02 in 2024, then tumbled by 744.0% to -$283.5 in 2025.
  • Its Times Interest Earned was -$283.5 in Q3 2025, compared to -$202.43 in Q2 2025 and -$1642.8 in Q1 2025.